Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Elliott’s public push for bigger buybacks and a more aggressive capital-return plan materially increases the upside to Air Liquide’s margin-strength story. This trade idea outlines a long trade with clear entry, stop and target levels, rationale centered on margin recovery, hydrogen and specialty gas tailwinds, and catalysts that could drive re-rat…
U.S. exchange-traded fund investors have steered flows toward short- and intermediate-maturity bonds as a global repricing of government yields raises interest-rate risk. Rising oil prices, concerns about government borrowing and heavy capital demand have pushed longer-term yields higher across major markets, prompting a preference for shorter-dura…
Chagee Holdings (CHA) is being upgraded to Positive on signs management is re-centering the business: Q2 margin recovery, continued store rollouts, strong cash-return optionality via a $150M repurchase and improving top-line stability. Technical momentum and a reasonable P/E (~11.5) support a mid-term swing buy at $12.56 with a $15.50 target and $1…
Signet Jewelers jumped in pre-market trading after reporting a second-quarter earnings beat and raising its fiscal 2027 adjusted EPS guidance. The company posted adjusted EPS of $2.19 versus a $1.72 analyst estimate, reported revenue of $1.5 billion roughly in line with expectations, and cited gains in same-store sales and merchandise average unit …
Snowflake reported another quarter of accelerating product revenue and raised full-year product revenue guidance to $6.07B, signaling stronger-than-expected enterprise AI demand. At $335.66 the stock still trades at a premium, but accelerating growth, improving unit economics and rich free cash flow create a favorable asymmetric trade. We present a…
Nvidia is facing a supply-constrained growth episode: demand for AI GPUs is outpacing what the company can ship. The stock has pulled back to $225.78 on profit-taking, creating a tradeable long entry that leans on Nvidia's dominant margins, massive free cash flow and backlog-driven pricing power. We lay out an entry at $224.00, stop at $200.00 and …
Inhibrx (INBX) produced clinical signals in its head-and-neck squamous cell carcinoma (HNSCC) program that, by conventional readouts, should have been viewed as a clear directional positive. The market's muted response creates a trade setup: enter at $118.01, stop $98.00, and target $155.29 over a long-term (180 trading days) horizon. The company h…
ParaZero Technologies Ltd. announced a Memorandum of Understanding with a leading European Defense Company to integrate its DefendAir net-based autonomous Counter-UAS system into armored vehicle platforms. This collaboration aims to enhance armored vehicle defense against attack drones by providing a physical interception layer that neutralizes hos…
Lumentum reported a headline $7.2 billion loss that masks a strong operating picture: revenue up 109% YoY, gross margins ~50%, and free cash flow of $300.1M. The market punished the stock for a large non-cash accounting item, creating a tactical entry for traders who want exposure to AI-driven optical component demand. This trade idea is a long wit…
RBC Capital Markets has begun analyst coverage of five major European pharmaceutical companies, assigning Outperform ratings to Roche and AstraZeneca and Sector Perform to Novartis, GSK and Sanofi. The bank assigned specific price targets and cited pipeline dynamics, recent trial setbacks and patent-expiry pressures as key factors shaping its views…
Nano-X Imaging Ltd announced its Q2 2026 financial results with revenues rising 37% year-over-year driven by its Nanox Health IT acquisition. The company expanded U.S. and Latin American distribution, launched its first Nanox Imaging Network site, and advanced AI-based solutions commercial momentum. It undertook a restructuring of Korean operations…
Amazon is preparing to raise 4 billion pounds in its inaugural sterling bond sale, a four-part transaction that attracted more than 12 billion pounds of demand, according to a lead manager involved in the deal. The offering reflects a broader move by hyperscalers to tap markets outside the United States to finance expanding capital needs tied to ar…
SIFCO Industries has quietly moved from loss-making quarters into consistent profitability, with improving margins, positive free cash flow and low leverage. The market is focused on flat revenue and a high P/E; we see a path to rerating if margins hold and backlog or aftermarket demand accelerates. This is a tactical long trade with defined entry,…
Nvidia ($225.78) is more than a GPU vendor today. Its DGX Cloud, Omniverse, vGPU, and high-performance networking form an alternative AI stack that lets enterprises and cloud builders build outside AWS/GCP/Azure. Strong cash generation (FCF $127B) and high returns (ROE ~84%) justify a premium valuation, but competition, custom silicon, and executio…
HP Inc. announced a collaboration with Red Hat and NVIDIA to develop an open, enterprise-grade AI platform combining HP's ZGX Fury hardware with Red Hat AI Factory and NVIDIA's AI technology. This platform is designed to run AI inference closer to users, machines, and data, enabling improved AI performance, reduced setup times, and enhanced operati…
Quantum-Si is expanding its Proteus roadshow with additional stops in both the United States and Europe to advance market education and customer engagement ahead of the commercial launch of its single-molecule protein sequencing platform. The roadshow includes seminars in collaboration with academic, clinical, and biopharma partners, targeting rese…
WW International, Inc., known for its science-backed weight management programs, announced the appointment of Stephen Bye as its new President and CEO. Bye brings over 30 years of leadership experience in consumer subscription and technology businesses, having previously led Ookla and held senior roles at DISH Network, Sprint, and others. His exper…
Incannex Healthcare has started dosing patients in its Phase 2 dose-optimization trial (DReAMzz) of IHL-42X for obstructive sleep apnea, following positive prior Phase 2 data and FDA Fast Track designation. The company also received a US patent covering IHL-42X composition expiring in 2040 and holds approximately $70 million in cash with no debt. A…
Firefly Aerospace has signed a multi-launch agreement with SSC Space for two launches of its Alpha rocket from Sweden's Esrange Space Center targeted for no earlier than 2028. This deal provides Sweden and European customers with new orbital launch services from mainland Europe and marks the start of a long-term partnership between Firefly and SSC …
NeOnc Technologies Holdings, Inc., a clinical-stage biopharmaceutical company focused on CNS cancer therapies, announced a $15 million registered direct offering of common stock and warrants at a combined price of $4.20 per share. The offering targets new and existing healthcare-focused institutional investors and is expected to close around Septem…
PowerCompute, Inc. provided an operational update for August 2026, highlighting consistent Bitcoin mining production of 7.9 BTC, energy sales generated through power curtailment amounting to approximately $132,000, and bitcoin holdings value of $25.2 million. The company is advancing its mining capabilities by ordering 1,000 new miners, anticipatin…
IN8bio, a clinical-stage biopharmaceutical company focused on γδ T cell therapies, has appointed Dr. Oxana Polyakova as Senior Vice President of Research & Development. Dr. Polyakova brings two decades of expertise in γδ T cell biology and T cell engager therapeutics, strengthening IN8bio's leadership as they advance their pipeline targeting oncolo…
Ascent Solar Technologies has appointed Tom Bawol as Director of Strategic Sales & Market Development and LTG Steve Smith as Strategic Advisor, bringing extensive military leadership and business development experience. These appointments aim to accelerate the commercial adoption of Ascent's flexible thin-film photovoltaic solutions in markets such…
Jasper Therapeutics, a clinical stage biotech company focusing on immune-mediated disease therapies, announced its upcoming presentation at the H.C. Wainwright 28th Annual Global Investment Conference. Management will participate in a fireside chat to discuss the company's pipeline and clinical progress.
Adagene Inc., a clinical-stage biotechnology company, announced the achievement of a preclinical milestone with Exelixis relating to its SAFEbody platform. This milestone pertains to the development of XB404, an antibody-drug conjugate targeting ROR1/2-expressing tumors, which triggered a $2 million payment from Exelixis. Additional payments were a…
